Product profile

Erflozin-M

ErtugliRozin + Metformin

Product overview

Regulatory-friendly overview of dosage forms and commercial presentations.

This page summarizes the current product entry from the supplied catalogue source.

Active ingredient

ErtugliRozin + Metformin

Therapeutic area

Hypoglycemics

Available dosage forms

Tablet

Available strengths

2.5mg + 1000mg; 2.5mg + 500mg; 2.5mg + 850mg; 7.5 + 1000mg; 7.5mg + 500mg; 7.5mg + 850mg

Pack sizes

14’s

Presentations

1

Regulatory note

This catalogue is informational only. Pricing, promotional claims, and market-specific availability are not shown.

Catalogue access

Need the complete portfolio? Download the source file used for this catalogue.

Commercial presentations

Erflozin-M

Available strengths and pack sizes are listed below exactly as provided in the source file.

Therapeutic areaGenericDosage formStrengthPack size
HypoglycemicsErtugliRozin + MetforminTablet2.5mg + 1000mg; 2.5mg + 500mg; 2.5mg + 850mg; 7.5 + 1000mg; 7.5mg + 500mg; 7.5mg + 850mg14’s